Genomic Analysis of Plasma Cell-Free DNA for Lung Cancer Management: An Imperfect Biomarker, But We Love It Anyway

Overview

Plasma cell-free DNA is a compelling but complex biospecimen which we now use routinely in the care of lung cancer patients. This talk will review strategies for effectively interpreting results from plasma genotyping, well as methods for incorporating these assays into lung cancer care and lung cancer research.

Following the presentation, there will be ample time for discussion and a question/answer session.  Attendees will be able to submit questions and comments to Dr. Oxnard and Dr. Govindan via internet chat.

Date
Apr 10, 2018 -
Apr 10, 2018
Location

Online

After attending this webinar, participants will be able to:

  • Assess the current role of genomic analysis of plasma cell-free DNA in the management of lung cancer.
  • Discuss strategies to incorporate these assays into standard clinical management of lung cancer.
  • Identify ongoing clinical trials likely to further elucidate the role and affect the use of genomic analysis in the near future.

Geoffrey R. Oxnard, MD
Damon Runyon-Gordon Family Clinical Investigator, Associate Professor of Medicine, Dana Farber Cancer Institute, Harvard Medical School.

Program Chair- Ramaswamy Govindan, MD
Director, Section of Medical Oncology, Professor of Medicine, Anheuser-Busch Endowed Chair in Medical Oncology, Director, Section of Oncology, Washington University School of Medicine.

For any inquiries, please contact meetings@iaslc.org.

After attending this webinar, participants will be able to:

  • Assess the current role of genomic analysis of plasma cell-free DNA in the management of lung cancer.
  • Discuss strategies to incorporate these assays into standard clinical management of lung cancer.
  • Identify ongoing clinical trials likely to further elucidate the role and affect the use of genomic analysis in the near future.

Geoffrey R. Oxnard, MD
Damon Runyon-Gordon Family Clinical Investigator, Associate Professor of Medicine, Dana Farber Cancer Institute, Harvard Medical School.

Program Chair- Ramaswamy Govindan, MD
Director, Section of Medical Oncology, Professor of Medicine, Anheuser-Busch Endowed Chair in Medical Oncology, Director, Section of Oncology, Washington University School of Medicine.

For any inquiries, please contact meetings@iaslc.org.

Share